ESTA
What one share of Establishment Labs Holdings holds
Orthopedic, Prosthetic and Surgical Appliances and Supplies
We are a global medical technology company focused on improving patient safety and aesthetic outcomes, initially in the breast aesthetics and reconstruction market. We initially incorporated in Costa Rica in 2004 and subsequently reorganized in 2013 under a parent holding company in the British Virgin Islands.
Establishment Labs Holdings’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $8.14 |
|---|---|
| Profit | −$1.29 |
| Capex (buildings and equipment) | $0.30 |
| Free cash flow | −$1.37 |
| Cash and investments | $2.39 |
| Debt | $8.78 |
| Book value | $0.73 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2017 | $3.39 | −$3.41 | $0.09 | −$3.21 | — | −$0.49 |
| 2018 | $3.53 | −$1.22 | $0.10 | −$2.05 | — | $3.43 |
| 2019 | $4.36 | −$1.86 | $0.31 | −$1.77 | — | $1.92 |
| 2020 | $3.63 | −$1.64 | $0.09 | −$0.63 | — | $3.19 |
| 2021 | $5.28 | −$1.72 | $0.10 | −$1.25 | — | $2.11 |
| 2022 | $6.61 | −$3.08 | $0.12 | −$2.25 | — | −$0.34 |
| 2023 | $6.45 | −$3.07 | $0.31 | −$3.77 | — | $0.71 |
| 2024 | $5.90 | −$3.00 | $0.22 | −$2.29 | — | $1.84 |
| 2025 | $7.13 | −$1.72 | $0.20 | −$1.92 | — | $0.80 |